At Becker’s 16th Annual Meeting, healthcare leaders gathered at an Optum-sponsored executive roundtable to discuss AI in action—and the clinical and financial value it’s delivering today. The ...

AI can augment oncology nursing through symptom triage support, trial matching, care plan personalization, pharmacogenomics ...

Rob DiCicco, vice president of portfolio management, and Bill Illis, workstream leader, digital data flow at TransCelerate ...

Not all AI is created clinical; Wolters Kluwer experts stress clinician-led development for reliable medication intelligence ...

In an all-comer PROC population, across multiple dose cohorts, manageable safety profile of the combination was observed with low frequency of high-grade adverse eventsActivity of the combined regimen ...

Company is Entering a Pivotal Phase to Demonstrate Value of its Unique Oral Vaccine Platform Emphasizes Need for the Right Board Leadership at ...

Most health care professionals in the U.S. said they would consider prescribing combination levothyroxine and liothyronine ...

Discover how building USCDI compliance into the healthcare integration layer ensures reliable, standardized data exchange.

Drug developers have delivered promising news in the fields of cancer, cardioprotection, delirium and motor system atrophy.

Safety and efficacy results from the Phase 3 INDIGO trial to be presented by Emanuel Della Torre, M.D., Ph.D., on Thursday June 4, 2026, at ...

Parabilis Medicines, Inc.’s IPO spotlights Helicon peptide cancer drugs like zolucatetide, plus Regeneron’s $125M backing & ...

EarSmartAI is a Portfolio Company of Boomerang Ventures INDIANAPOLIS, IN / ACCESS Newswire / May 21, 2026 / Ear ...